Patents by Inventor Karsten Mahnke

Karsten Mahnke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ROTOR COMPRISING A ROTOR COMPONENT ARRANGED BETWEEN TWO ROTOR DISCS
    Publication number: 20240084708
    Abstract: A rotor of a gas turbine having two adjacent rotor discs, on each of which moving blades are fastened, an annular rotor component being arranged between the rotor discs and having at its opposite ends circumferential annular grooves, in each of which a circumferential fastening projection on the respective rotor disc engages. When the rotor is stationary a first outer flank of the first annular groove rests under pressure against a first outer flank of the first fastening projection and there is play between a first inner flank of the first annular groove and a first inner flank of the first fastening projection.
    Type: Application
    Filed: June 18, 2020
    Publication date: March 14, 2024
    Applicant: Siemens Energy Global GmbH & Co. KG
    Inventors: Peter Kury, Mirko Milazar, Christopher W Ross, Yulia Bagaeva, Karsten Kolk, Ivan Lbov, Alexander Romanov, Harald Hoell, Kevin Kampka, Rene Mahnke, Andreas Andreas, Daniel Hofsommer, Ekkehard Maldfeld, Jörg Richter
  • Treatment of inflammatory airway disease
    Patent number: 7795223
    Abstract: This invention relates to methods of treatment of inflammatory airway disease, and in particular to methods of treatment of asthma and chronic obstructive pulmonary disease. The invention is applicable to both allergic (atopic) and non-allergic (intrinsic) asthma. In one form the method comprises the step of administering an effective amount of a compound which has the ability to inhibit one or more functions of the T cell receptor (TCR) to a subject in need of such treatment, which is preferably a peptide whose sequence is derived from an invariant region of (a) the TCR? transmembrane domain; (b) the TCR? transmembrane domain; (c) the TCR? intracellular domain; or (d) the CD3-?, -?, -?, ? or ? chain.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: September 14, 2010
    Assignee: Novozymes Biopharma Au Ltd.
    Inventors: Alexander Enk, Karsten Mahnke
  • Treatment of Inflammatory Airway Disease
    Publication number: 20080200394
    Abstract: This invention relates to methods of treatment of inflammatory airway disease, and in particular to methods of treatment of asthma and chronic obstructive pulmonary disease. The invention is applicable to both allergic (atopic) and non-allergic (intrinsic) asthma. In one form the method comprises the step of administering an effective amount of a compound which has the ability to inhibit one or more functions of the T cell receptor (TCR) to a subject in need of such treatment, which is preferably a peptide whose sequence is derived from an invariant region of (a) the TCR? transmembrane domain; (b) the TCR? transmembrane domain; (c) the TCR? intracellular domain; or (d) the CD3-?, -?, -?, ? or ? chain.
    Type: Application
    Filed: May 27, 2005
    Publication date: August 21, 2008
    Applicant: GROPEP LIMITED
    Inventors: Alexander Enk, Karsten Mahnke